查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447940

全球医疗报销市场 - 全球产业分析、规模、占有率、成长、趋势、预测（2023-2030） - 按索赔、按付款人、按服务提供者、按地区、按公司

Healthcare Reimbursement Market - Global Healthcare Reimbursement Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Claim Coverage, By Payer Coverage, By Service Provider Coverage, By Geographic Coverage and By Company)
出版日期: | 出版商: Fairfield Market Research | 英文 216 Pages | 商品交期: 2-5个工作天内

价格
简介目录

医疗报销市场规模即将大幅成长。 2022年为112亿美元，从2023年到2030年，预计将以18.2%的惊人复合年增长率（CAGR）成长，到2030年达到361亿美元。

支持这一前所未有的成长轨蹟的关键因素之一是医疗保健应用程式的日益普及。 电子健康记录 (EHR)、远距医疗和数据分析等技术创新透过提高效率和准确性正在彻底改变报销流程。 这些进步透过简化索赔处理、减少错误并确保透明的索赔操作，推动了对创新报销解决方案的需求。

此外，医疗费用的上涨和慢性病盛行率的增加也大大促进了市场的扩张。 随着医疗保健成本持续上升，对高效、透明的报销流程的需求不断增长。 因此，必须制定创新的报销模式和基于价值的护理策略，以有效管理成本，同时确保为慢性病患者提供及时、适当的护理。

本报告考察了全球医疗报销市场，并提供了市场概述，以及按帐单金额、付款人、服务提供者、地区、公司以及进入市场的公司的竞争趋势等划分的趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2030年全球医疗报销市场前景

  • 2018-2030 年全球医疗报销市场前景（按理赔金额（十亿美元）划分）
  • 2018-2030 年全球医疗报销市场前景（按付款人划分）、金额（十亿美元）
  • 2018-2030 年全球医疗保健报销市场前景（按服务提供者划分），金额（十亿美元）
  • 2018-2030 年全球医疗报销市场前景（按地区、金额（十亿美元））

第四章2018-2030年北美医疗报销市场前景

第五章欧洲医疗报销市场前景，2018-2030

第六章2018-2030年亚太地区医疗报销市场前景

第七章拉丁美洲医疗报销市场展望，2018-2030

第8章2018-2030年中东及非洲医疗报销市场前景

第九章竞争态势

  • 服务提供者和计费热图
  • 2022 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • UnitedHealth Group
    • Anthem, Inc.
    • Cigna
    • Humana Inc.
    • Blue Cross Blue Shield Association
    • Centene Corporation
    • Molina Healthcare
    • Kaiser Permanente
    • CVS Health
    • Tenet Healthcare
    • HCA Healthcare
    • Magellan Health
    • Universal American
    • Gateway Health The Joint Commission

第 10 章附录

简介目录

Healthcare reimbursement market is set to experience exponential growth, according to the latest report by [Your Company/Institution]. With an estimated worth of US$11.2 billion in 2022, the market is forecasted to soar to US$36.1 billion by 2030, reflecting a staggering Compound Annual Growth Rate (CAGR) of 18.2% during the period of 2023 to 2030.

Fueling Factors Behind Growth

Advancements in Healthcare Technology

One of the primary drivers behind this unprecedented growth trajectory is the increasing popularity of healthcare applications. Technological innovations, including electronic health records (EHRs), telemedicine, and data analytics, are revolutionizing reimbursement processes by enhancing efficiency and accuracy. These advancements streamline claims processing, reduce errors, and ensure transparent billing practices, thereby driving the demand for innovative reimbursement solutions.

Rising Healthcare Expenditure and Chronic Disease Prevalence

Moreover, rising healthcare costs coupled with the increasing prevalence of chronic diseases are significant contributors to market expansion. As healthcare expenses continue to escalate, there is a growing demand for efficient and transparent reimbursement processes. This necessitates the development of innovative reimbursement models and value-based care strategies to manage costs effectively while ensuring timely and appropriate care for patients with chronic conditions.

Key Trends and Opportunities

Telehealth Integration

Telehealth integration emerges as a pivotal trend in the healthcare reimbursement market, facilitating accurate billing and payment processes for virtual healthcare services. By automating claims submission and supporting transparent billing practices, telehealth integration ensures efficient reimbursement in the evolving healthcare landscape.

Electronic Health Records (EHRs) and Robotic Process Automation (RPA)

Integration of EHR systems and RPA technology further optimizes reimbursement workflows by enhancing data accuracy and automating repetitive tasks. These innovations reduce administrative burdens and accelerate reimbursement processes, ultimately driving market growth.

Challenges and Opportunities

Complex Regulations and Administrative Burden

However, the market faces challenges due to complex regulations and administrative burdens. Navigating intricate compliance requirements and evolving regulatory landscapes requires continuous training and technology updates. Streamlining administrative tasks through automation and improved technology presents an opportunity to alleviate this challenge and enhance reimbursement efficiency.

Regional Dynamics

North America's Leadership and Asia Pacific's Growth Prospects

North America leads the global healthcare reimbursement market, driven by its advanced healthcare infrastructure and extensive insurance coverage. In contrast, Asia Pacific witnesses rapid growth fueled by increasing healthcare investments and expanding insurance coverage. The adoption of advanced technologies and evolving reimbursement policies align with the region's modernization efforts, making it a dynamic and rapidly expanding market.

Competitive Landscape

Leaders in the Global Healthcare Reimbursement Market

The market is dominated by key players such as Magellan Health, UnitedHealth Group, Anthem, Inc., Cigna, and Humana Inc. These companies are introducing new products and enhancing distribution channels to consolidate their global presence. More consolidation is expected in the coming years, further shaping the competitive landscape of the healthcare reimbursement market.

Global Healthcare Reimbursement Market is Segmented as Below:

By Claim:

  • Fully Paid
  • Underpaid

By Payer:

  • Private Payers
  • Public Payers

By Service Provider:

  • Physician Office
  • Hospitals
  • Diagnostic Laboratories
  • Others

By Geographic Coverage:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Egypt
    • Nigeria
    • Rest of the Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Healthcare Reimbursement Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 3.1. Global Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Fully Paid
      • 3.1.1.2. Underpaid
  • 3.2. Global Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Private Payers
      • 3.2.1.2. Public Payers
  • 3.3. Global Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Physician Office
      • 3.3.1.2. Hospitals
      • 3.3.1.3. Diagnostic Laboratories
      • 3.3.1.4. Others
  • 3.4. Global Healthcare Reimbursement Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 4.1. North America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Fully Paid
      • 4.1.1.2. Underpaid
  • 4.2. North America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Private Payers
      • 4.2.1.2. Public Payers
  • 4.3. North America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Physician Office
      • 4.3.1.2. Hospitals
      • 4.3.1.3. Diagnostic Laboratories
      • 4.3.1.4. Others
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 4.4.1.2. U.S. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 4.4.1.3. U.S. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 4.4.1.4. U.S. Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
      • 4.4.1.5. Canada Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 4.4.1.6. Canada Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 4.4.1.7. Canada Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 4.4.1.8. Canada Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 5.1. Europe Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Fully Paid
      • 5.1.1.2. Underpaid
  • 5.2. Europe Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Private Payers
      • 5.2.1.2. Public Payers
  • 5.3. Europe Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Physician Office
      • 5.3.1.2. Hospitals
      • 5.3.1.3. Diagnostic Laboratories
      • 5.3.1.4. Others
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.2. Germany Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.3. Germany Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.4. U.K. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.5. U.K. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.6. U.K. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.7. France Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.8. France Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.9. France Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.10. Italy Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.11. Italy Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.12. Italy Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.13. Turkey Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.14. Turkey Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.15. Turkey Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.16. Russia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.17. Russia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.18. Russia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 5.4.1.19. Rest of Europe Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 5.4.1.20. Rest of Europe Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 5.4.1.21. Rest of Europe Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Fully Paid
      • 6.1.1.2. Underpaid
  • 6.2. Asia Pacific Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Private Payers
      • 6.2.1.2. Public Payers
  • 6.3. Asia Pacific Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Physician Office
      • 6.3.1.2. Hospitals
      • 6.3.1.3. Diagnostic Laboratories
      • 6.3.1.4. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.2. China Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.3. China Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.4. Japan Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.5. Japan Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.6. Japan Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.7. South Korea Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.8. South Korea Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.9. South Korea Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.10. India Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.11. India Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.12. India Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.13. Southeast Asia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.14. Southeast Asia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.15. Southeast Asia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 6.4.1.16. Rest of Asia Pacific Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 6.4.1.17. Rest of Asia Pacific Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 6.4.1.18. Rest of Asia Pacific Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 7.1. Latin America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Fully Paid
      • 7.1.1.2. Underpaid
  • 7.2. Latin America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Private Payers
      • 7.2.1.2. Public Payers
  • 7.3. Latin America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Physician Office
      • 7.3.1.2. Hospitals
      • 7.3.1.3. Diagnostic Laboratories
      • 7.3.1.4. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.2. Brazil Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.3. Brazil Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.4. Mexico Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.5. Mexico Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.6. Mexico Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.7. Argentina Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.8. Argentina Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.9. Argentina Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 7.4.1.10. Rest of Latin America Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 7.4.1.11. Rest of Latin America Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 7.4.1.12. Rest of Latin America Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Healthcare Reimbursement Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Fully Paid
      • 8.1.1.2. Underpaid
  • 8.2. Middle East & Africa Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Private Payers
      • 8.2.1.2. Public Payers
  • 8.3. Middle East & Africa Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Physician Office
      • 8.3.1.2. Hospitals
      • 8.3.1.3. Diagnostic Laboratories
      • 8.3.1.4. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.2. GCC Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.3. GCC Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.4. South Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.5. South Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.6. South Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.7. Egypt Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.8. Egypt Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.9. Egypt Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.10. Nigeria Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.11. Nigeria Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.12. Nigeria Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
      • 8.4.1.13. Rest of Middle East & Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
      • 8.4.1.14. Rest of Middle East & Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
      • 8.4.1.15. Rest of Middle East & Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Service Provider vs Claim Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. UnitedHealth Group
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Anthem, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Cigna
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Humana Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Blue Cross Blue Shield Association
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Centene Corporation
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Molina Healthcare
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Kaiser Permanente
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. CVS Health
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Tenet Healthcare
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. HCA Healthcare
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Magellan Health
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Universal American
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Gateway Health
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. The Joint Commission
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations